GlassScriptPhysician profile
Tseghai Berhe
NPI 1982678207
$8,842.14
in general payments reported to CMS, 2019-2025
42 companies · $684 in 2025
The $684 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,993 · 2020: $631 · 2021: $940 · 2022: $735 · 2023: $966 · 2024: $892 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,542.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,715.51 | 2019-2025 | Sogroya, Rybelsus, Ozempic |
| Ascendis Pharma Endocrinology INC | $879.01 | 2022-2025 | Skytrofa |
| Mannkind Corporation | $659.10 | 2019-2025 | Afrezza |
| Abbvie INC. | $430.93 | 2019-2023 | Lupron Depot |
| Tolmar Pharmaceuticals, INC. | $263.83 | 2020-2022 | |
| Neurocrine Biosciences, INC. | $255.83 | 2025 | |
| Kyowa Kirin, INC. | $245.39 | 2024-2025 | Crysvita |
| Xeris Pharmaceuticals, INC. | $238.25 | 2020-2023 | Recorlev |
| Insulet Corporation | $237.87 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $197.39 | 2023-2024 | |
| Medtronic, INC. | $174.44 | 2021-2025 | Minimed 780g |
| Dexcom, INC. | $160.98 | 2019-2023 | Dexcom G6 Transmitter |
| Sandoz INC. | $147.01 | 2019-2020 | |
| Pfizer INC. | $124.77 | 2019-2023 | |
| Zealand Pharma US, INC. | $101.32 | 2021-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $87.83 | 2019-2022 | |
| Lifescan, INC. | $84.65 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $82.71 | 2021 | |
| Endo USA, INC. | $74.19 | 2025 | Supprelin |
| Tandem Diabetes Care, INC. | $73.71 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic Minimed, INC. | $63.92 | 2019 | |
| Alexion Pharmaceuticals, INC. | $48.03 | 2023 | Strensiq |
| Astrazeneca Pharmaceuticals LP | $47.11 | 2019-2020 | |
| Beta Bionics, INC. | $45.16 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Acella Pharmaceuticals, LLC | $40.93 | 2024-2025 | NP Thyroid 60 |
| Amgen INC. | $37.02 | 2019 | |
| Embecta Corp. | $30.97 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Arbor Pharmaceuticals, INC. | $27.13 | 2019-2021 | |
| Ascensia Diabetes Care US INC. | $25.96 | 2024 | |
| Corcept Therapeutics | $25.26 | 2024 | Korlym |
| Eton Pharmaceuticals, INC. | $24.04 | 2023 | Alkindi |
| Rhythm Pharmaceuticals, INC. | $22.97 | 2025 | Imcivree |
| Amryt Pharma Holdings LTD | $21.99 | 2023 | Myalept |
| Lilly USA, LLC | $21.36 | 2019 | |
| Tolmar, INC. | $20.59 | 2023 | |
| Abbott Laboratories | $18.81 | 2020 | |
| Horizon Therapeutics Plc | $15.39 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.16 | 2019 | |
| Vistapharm, INC. | $14.50 | 2021 | |
| Biomarin Pharmaceutical INC. | $14.31 | 2024 | Voxzogo 1.2mg |
| Companion Medical, INC. | $14.00 | 2019 | |
| Ibsa Pharma INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tseghai Berhe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.